As of 2026-04-02, the Relative Valuation of MEI Pharma Inc (MEIP) is 10.10 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.07 USD, the upside of MEI Pharma Inc based on Relative Valuation is 228.8%.
The range of the Relative Valuation is 9.74 - 10.50 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 21.4x - 23.1x | 22.2x |
| Fair Price | 9.74 - 10.50 | 10.10 |
| Upside | 217.3% - 242.2% | 228.8% |
| Date | P/E |